Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Serine and Fenofibrate Study in Patients With MacTel Type 2
Phase 2
Active, not recruiting
- Conditions
- Macular Telangiectasia Type 2
- Interventions
- Dietary Supplement: Serine
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- The Lowy Medical Research Institute Limited
- Target Recruit Count
- 60
- Registration Number
- NCT04907084
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Retina Associates of Cleveland, Cleveland, Ohio, United States
MacTel Laser Study
Not Applicable
Completed
- Conditions
- Macular Telangiectasia
- First Posted Date
- 2017-10-26
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- The Lowy Medical Research Institute Limited
- Target Recruit Count
- 9
- Registration Number
- NCT03321916
- Locations
- 🇺🇸
Medical College of Wisconsin & Froedtert Hospital, Milwaukee, Wisconsin, United States
MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin
- Conditions
- Macular TeleangiectasiaMacular Pigment
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2007-12-06
- Lead Sponsor
- The Lowy Medical Research Institute Limited
- Target Recruit Count
- 12
- Registration Number
- NCT00568828
- Locations
- 🇩🇪
Dep. of Ophthalmology, St. Franziskus Hospital, Muenster, Germany
News
No news found